ACTIVE_NOT_RECRUITING

Increasing Adherence to Lung Cancer Screening

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Investigators are conducting a pragmatic randomized trial testing the effectiveness of patient and clinician nudge strategies on adherence to lung cancer screening (LCS) \& diagnostic follow-up across eligible primary care clinicians \& patients. Following the trial, a subsample of patients \& clinicians will be invited to one-time semi-structured interview \& survey to identify individual \& system-level factors that may restrict or enhance the impact of strategies.

Official Title

Increasing Equitable Adherence to Annual Lung Cancer Screening and Diagnostic Follow-up

Quick Facts

Study Start:2023-06-18
Study Completion:2026-02-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT05832008

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. are practicing primary care or specialty care physicians at a recruiting site within the University of Pennsylvania Health System;
  2. 2. care for patients who completed LCS via LDCT in 2019-2023; and
  3. 3. do not opt-out of study participation.
  4. 1. are eligible for LCS based on 2021 US Preventive Services Task Force (USPSTF) population guidelines (aged 50-80; smoking history of 20-pack years; smoked within the last 15 years)
  5. 2. completed LCS via LDCT in 2019-2023;
  6. 3. have not been diagnosed with lung cancer;
  7. 4. meet criteria for non-adherence;
  8. 5. remain eligible for LCS during the trial enrollment period; and
  9. 6. receive LCS care from a clinician that has not opted-out of study participation
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Principal Investigator

Katharine Rendle, PhD,MSW,MPH
PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Anil Vachani, MD
PRINCIPAL_INVESTIGATOR
University of Pennsylvania

Study Locations (Sites)

University of Pennsylvania
Philadelphia, Pennsylvania, 19104
United States

Collaborators and Investigators

Sponsor: Abramson Cancer Center at Penn Medicine

  • Katharine Rendle, PhD,MSW,MPH, PRINCIPAL_INVESTIGATOR, University of Pennsylvania
  • Anil Vachani, MD, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-18
Study Completion Date2026-02-01

Study Record Updates

Study Start Date2023-06-18
Study Completion Date2026-02-01

Terms related to this study

Keywords Provided by Researchers

  • Screening
  • Nudge
  • Adherence
  • Implementation science
  • Behavioral science
  • Digital health

Additional Relevant MeSH Terms

  • Lung Cancer
  • Adherence, Patient